KYMR insider proposes sale of 2,500 shares

KYMR: Pamela Esposito filed a Form 144 proposing the sale of 2,500 common shares related to an exercise of stock options for cash, with the transaction dated 02/20/2026.

Accepted by SEC EDGAR 02/20/2026 - 04:28 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

KYMR: Pamela Esposito filed a Form 144 proposing the sale of 2,500 common shares related to an exercise of stock options for cash, with the transaction dated 02/20/2026. The filing lists prior sales in the past three months: 5,500 shares on 01/20/2026 for $373,521.20 and 27,563 shares on 12/17/2025 for $2,264,479.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 for KYMR disclose?

The Form 144 discloses a proposed sale of 2,500 shares tied to an exercise of stock options dated 02/20/2026. It also records two prior sales of 5,500 and 27,563 shares in the three months before the filing.

Who is the reporting person on the KYMR Form 144?

The reporting person is Pamela Esposito, with address listed as 500 North Beacon Street, 4th Floor, Watertown, MA. The broker/dealer shown is Morgan Stanley Smith Barney LLC, Executive Financial Services at 1 New York Plaza, New York.

How much cash was reported from recent insider sales for KYMR?

Recent proceeds reported: $373,521.20 and $2,264,479.00 from sales on 01/20/2026 and 12/17/2025, respectively. The proposed sale on 02/20/2026 is tied to option exercise for cash.

What method is used for the proposed KYMR sale?

The proposed sale arises from an exercise of stock options and is to be settled in cash, dated 02/20/2026. The filing lists prior 10b5-1 sales as separate transactions in the prior three months.

Does the Form 144 show an active 10b5-1 plan for KYMR insider?

Yes, the filing references 10b5-1 sales for Pamela Esposito, with recorded executions on 01/20/2026 (5,500 shares) and 12/17/2025 (27,563 shares), consistent with planned sales under such arrangements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001744425
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KYMERA THERAPEUTICS, INC.
SEC File Number	001-39460
Address of Issuer	500 North Beacon Street, 4th Floor Watertown MASSACHUSETTS 02472
Phone	8572855300
Name of Person for Whose Account the Securities are To Be Sold	PAMELA ESPOSITO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	216250.00	71949027	02/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/20/2026	Exercise of Stock Options	Issuer			2500	02/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PAMELA ESPOSITO 500 North Beacon Street, 4th Floor Watertown MA 02472	Common	01/20/2026	5500	373521.20
10b5-1 Sales for PAMELA ESPOSITO 500 North Beacon Street, 4th Floor Watertown MA 02472	Common	12/17/2025	27563	2264479.00

144: Remarks and Signature

Remarks
Date of Notice	02/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Pamela Esposito
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)